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and Degenerative Joint Disease
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Objective. Osteoarthritis (OA) is a common de-
bilitating disease that results in degeneration of carti-
lage and bone in the synovial joints. Subtle changes in
the molecular structure of the subchondral bone matrix
occur and may be associated with cartilage changes. The
aim of this study was to explore whether the abnormal
molecular changes observed in the matrix of OA sub-
chondral bone can be identified with Raman spectros-
copy.
Methods. Tibial plateaus from patients undergo-
ing total knee replacement for OA (n  10) were
compared with healthy joints from patients undergoing
leg amputation (n 5; sex- and laterality-matched) and
with non-OA cadaveric knee specimens (n  5; age-
matched). The samples were analyzed with Raman
spectroscopy, peripheral quantitative computed tomog-
raphy, and chemical analysis to compare changes in
defined load-bearing sites in both the medial and lateral
compartments.
Results. OA subchondral bone matrix changes
were detected by Raman spectroscopy. Within each
cohort, there was no spectral difference in bone matrix
chemistry between the medial and lateral compart-
ments, whereas a significant spectral difference (P <
0.001) was observed between the non-OA and OA spec-
imens. Type I collagen chain ratios were normal in the
non-OA specimens but were significantly elevated in
the OA specimens.
Conclusion. In comparing the results of Raman
spectroscopy with those obtained by other standard
techniques, these findings show, for the first time, that
subchondral bone changes, or inherent differences, exist
in both the medial and lateral (beneath intact cartilage)
compartments of OA knees. The development of Raman
spectroscopy as a screening tool, based on molecular-
specific modifications in bone, would facilitate the iden-
tification of clinical disease, including early molecular
changes.
Synovial joints allow movement, consist of multi-
ple tissues and structures, and are considered to be
skeletal organs. Osteoarthritis (OA) is a condition of
multifactorial organ failure in which pathologic changes
in the cartilage, bone, synovium, and other periarticular
soft tissues interact (1). This structural failure causes
inhibited function of the joint and, combined with
chronic pain, results in debilitation and reduced quality
of life.
Indications of disease progression include de-
struction of the cartilage in combination with abnormal
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thickening of the subchondral bone and gross deformity
of the affected joint (2). The quality of bone, as a
material, may have been underestimated in the under-
standing of the etiology and progression of disease (3).
The interaction between cartilage and subchondral bone
and its role in the pathogenesis of OA require further
examination, and may provide a mechanical basis for the
cartilage degradation process (4,5). It is possible that not
one single tissue is responsible (6). Clarification as to
whether specific biomolecular changes occur in the
onset of OA (7,8) is needed.
To date, relatively little is known about the
relationship between bone (material), structural compe-
tence, and the mechanobiologic interaction of bone and
cartilage in the etiology of OA, particularly in the
initiation and early stages of the disease. Two theories
have been proposed. One theory postulates that OA is
the result of altered impact mechanical loading, which
induces bone adaptation with subchondral bone thick-
ening, and leads to a stiffer structure (4). This new stiffer
structure is less effective at absorbing shock, and there-
fore the distribution of force through the affected joint
changes, leading to site-specific cartilage destruction.
The “chemical” nature or quality of the newly synthe-
sized bone as a material may be indistinguishable from
the original bone tissue.
Another theory postulates that an alteration in
bone matrix chemistry occurs as part of the disease
progression. This hypothesis is supported by studies of
OA bone, which show that the tropocollagen molecules
comprise 3 1 chains (rather than 2 1 chains and 1 2
chain) (9–12). Bone with homotrimeric collagen has a
lower modulus (4.3 GPa) than that with heterotrimeric
collagen (4.5 GPa), thus being less able to support the
overlying cartilage without a compensatory increase in
structural thickness (9,13). In addition, homotrimers
have higher water content (14). In this setting, subchon-
dral sclerosis or structural thickening could be a com-
pensatory attempt to provide support for cartilage in the
presence of abnormal bone matrix.
Conventional technologies, e.g., radiography, are
used to assess the extent of damage in OA joints,
particularly to identify joint space narrowing and thick-
ened subchondral bone. Vibrational spectroscopic tech-
niques, such as infrared or Raman spectroscopy, may
also be applied. The main benefit of spectroscopic
techniques over conventional techniques is the capabil-
ity to detect the organic and inorganic phases of bone,
effectively acquiring an overall biochemical signature,
without destructive sample preparation (15).
Raman spectroscopy has been used to assess
bone and pathologic changes in the tissue (16,17).
Spectral analysis has shown that the hydroxyapatite:
collagen ratio (mineral volume fraction), carbonate
apatite:hydroxyapatite ratio (carbonate substitution),
and amide III (protein conformation) are altered in
subchondral bone from the hip joints of patients with
OA (18), all of which are indicative of alterations in
bone composition and the collagen secondary structure.
In these studies, the nearby trabecular bone was not
similarly affected, and analysis of samples from the
most weight-bearing and least weight-bearing sites did
not alter the outcome (18). The increased levels of
homotrimeric collagen in the subchondral bone from
OA femoral heads (8) may result in the alterations in the
collagen secondary structure, as has been observed using
Raman spectroscopy (18).
Raman spectroscopy is a technique that measures
and quantifies the energetic changes in light (typically
generated by a laser) scattered from materials. When
light scatters from a sample, energy may be lost (or
gained) by some photons and a shift in wavelength is
observed to the red (energy loss) or the blue (energy
gained) region. The shifts in wavelength of the photons
are dependent on the chemicals within the material;
therefore, Raman spectroscopy gives a chemical “finger-
print,” which, when analyzed, identifies the components
present. The energy of the shifted light is plotted as a
spectrum of the intensity of scattered light (y-axis)
against the wave numbers (x-axis) (1 cm1  1  107/
wavelength in nm). Spectral bands for molecular func-
tional groups associated with mineralized tissue in-
clude phosphate, carbonate, amides I and III (indicators
of secondary protein conformation), proline, hydroxy-
proline, and lipids (19–21). The heights/areas of the
bands can be compared, e.g., the mineral:collagen ratio,
thus providing information on the organic and inorganic
phases of bone and the degree of mineralization of a
given specimen. Multivariate analyses of the Raman
spectra can discern subtle differences that cannot be
identified by eye. For example, principal components
analysis (PCA) may be applied to analyze the spread of
data and identify segregation of the spectra (22,23).
In this study, we explored the hypothesis that
changes in bone matrix chemistry in the subchondral
bone of the tibial plateau of patients with knee OA can
be detected by Raman spectroscopy. Furthermore, the
spectral distinction between OA and non-OA may be
identified as changes in the organic phase (amide
bands), which thereby result in a change in the mineral:
collagen ratio. The load-bearing regions of both the
medial (grossly affected) and lateral (not visually dam-
aged at a macroscopic level) compartments of human
tibial plateaus were probed independently, and samples
1238 KERNS ET AL
were sex-matched (with a subset age-matched) to
non-OA joints. The findings from Raman spectroscopy
(overall biochemical signature) along with the findings
obtained by peripheral quantitative computed tomog-
raphy (pQCT) (mineral component) and the -chain
ratio (organic component) were assessed for correlations.
PATIENTS AND METHODS
Samples. Human tibial plateaus were acquired from
patients with knee OA (n  10) following the patients’
provision of informed consent and ethics approval from the
Royal National Orthopaedic Hospital, UK (ethics approval no.
08/H0304/78). The tibial plateaus were obtained from patients
undergoing total knee replacement for established grade IV
(Outerbridge classification) medial compartment OA (radio-
graphic and macroscopic diagnosis). Control specimens were
collected from non-OA patients undergoing various operations
(due to different conditions of the proximal femur, with no
evidence of tibial involvement, no OA of the knee joint, and
without changes in clinically assessed load-bearing) requiring
removal of the leg (n  5). In addition, control samples were
obtained from non-OA cadaveric specimens (n  5, from 3
age-matched subjects) at Vesalius Clinical Training Centre,
University of Bristol (ethics approval no. 08/H0724/34). The
patients with OA (mean  SD age 68  15 years) and the
non-OA subjects (mean  SD age 75  15 years for the
cadaveric specimens and 30 18 years for the amputees) were
matched for sex and laterality. All non-OA specimens were
examined by an orthopedic surgeon, and no visual appearance
of OA was found, either macroscopically or radiographically.
Figure 1A shows a typical OA specimen, and Figure 1B is the
corresponding radiograph with evidence of clear joint space
narrowing and thickening of the medial subchondral bone.
Figures 1D and E show a non-OA equivalent specimen.
Samples were frozen at 80°C within 2 hours of
removal, for storage prior to analysis. Cadaveric specimens
were kept in storage at20°C at the Vesalius Clinical Training
Centre within 48 hours of death, and subsequently transported
frozen.
Peripheral QCT. The medial and lateral compartments
of the tibial plateaus were scanned using pQCT (XCT 3000;
Stratec) to determine volumetric bone mineral density
(vBMD) and thickness of the subchondral bone (Figures 1C
and F). The x-ray beam width was 2 mm and the voxel size was
fixed at 0.3 mm. Specimens were measured at 5-mm intervals
across the tibial plateau. A measurement slice from the center
of each compartment of the plateau (demarcated with the red
broken lines in Figures 1A and D) was used to calculate the
vBMD (in mg/cm3) of the subchondral bone; the regions of
Figure 1. Assessment of the tibial plateau from a patient with osteoarthritis (OA) compared to that from a non-OA control. Postoperative
photographs (A and D) and preoperative radiographs (B and E) of the medial (M) and lateral (L) tibial plateaus from a representative patient with
OA (A and B) and a non-OA control (D and E) are shown. The medial tibial plateau (C) and lateral tibial plateau (F) from a patient with OA were
assessed by peripheral quantitative computed tomography (pQCT). In the pQCT images, the region of interest is demarcated as a green box. The
red broken lines in A and D indicate the plane from which the pQCT measurements were obtained.
OSTEOARTHRITIC BONE MATRIX CHEMISTRY 1239
interest used were the same size and in the same location
across all measurements (Figures 1C and F). Additionally, the
thickness of the subchondral bone was measured (in mm).
Raman microspectroscopy. Cylindrical cores (dimen-
sion 12 mm2  height of plateau [range 10–20 mm]) were
extracted from the tibial plateaus using an 11-gauge Jamshidi
Crown bone marrow biopsy needle (Cardinal Health, France),
with 2 samples obtained from each compartment, correspond-
ing to the same sites analyzed by pQCT. The cores were turned
on their side, and spectra were acquired directly from the
subchondral bone (3 mm below the cartilage, if present)
using an InVia Raman microspectrometer (Renishaw). This
was equipped with an 830-nm laser, 300 mW at source.
Calibration was performed every day on silicon, as silicon has
a known Raman band (520.5 cm1), and on polystyrene to
measure bands in the same range as that of bone (wave
numbers between 1000 cm1 and 1030 cm1). There was no
difference across the values during the time of data collection.
The spectra were acquired at a laser power of 2 mW for 1
second and 4 accumulations; 5 different spectra were acquired
from the subchondral bone per core (total number of spec-
tra  400). The spatial resolution (at 50 objective) was
2 m 2 m. There was no thermal heating or degradation of
the samples at the laser powers utilized.
Lipid removal. The removal of lipids was required
because lipids are strong light scatterers on Raman microspec-
troscopy, having spectral peaks that overlie some of the
spectral peaks from bone matrix. Following established bone
preparation techniques (24,25), the cores were washed in 5 ml
of acetone on a roller for 1 hour at 37°C with constant agi-
tation. The acetone was removed and replaced with fresh
acetone twice. The cores were then rinsed in distilled H2O to
remove the acetone. The spectral measurements were then
repeated with the same parameters. The effect of lipid removal
with acetone was validated by comparing peak ratios, namely
the ratios of phosphate to amide I and phosphate to carbonate,
before and after lipid removal (details available from the
corresponding author upon request).
Polarization and orientation. The laser used gener-
ates polarized light, and certain materials/molecular bonds
that are preferentially orientated with respect to the laser
polarization can be more or less efficient at scattering light.
Therefore, it was important to assess the influence of polar-
ization and orientation on these specimens. All spectra, as
described above, were acquired without the polarizer and at
the same orientation (within 10°). Additional spectra were
acquired with a polarizer in place, i.e., the laser was fully po-
larized, under the same parameters and from the same loca-
tion (within 1 m) every 45° from 0° to 360°. Spectra were then
processed as described below, and the mineralization ratios
were calculated for the ratio of phosphate (1; 960 cm
1) to
amide I and the ratio of phosphate (4; 588 cm
1) to amide
III; of note, the former measure, being a symmetric mode, is
more sensitive to polarization (26) (details available from the
corresponding author upon request).
Type I collagen -chain analysis. Sample preparation.
Defatted cores of the subchondral bone were weighed and
then decalcified in 10 ml 10% EDTA for 1 week on a roller at
4°C. The cores were washed with deionized water (to remove
EDTA), and then reweighed and freeze-dried. Five milligrams
from each sample was isolated for further processing. These
cores were immersed in 1 ml 0.5M acetic acid with 25 g pepsin
(porcine gastric mucosa, 3,200–4,500 units/mg protein; Sigma)
added at 0.5% weight/weight of 5 mg cores. Samples were left
to digest with agitation for 2 days at 4°C. The supernatants
were collected following centrifugation at 3,000 revolutions per
minute for 30 minutes at 4°C, and freeze-dried overnight.
Sodium dodecyl sulfate–polyacrylamide gel electrophor-
esis (SDS-PAGE). The samples were dissolved in 0.5 ml of
SDS-PAGE sample buffer (125 mM Tris [pH 6.8], 2% SDS,
Figure 2. Average intensity of the Ramen spectra (wave numbers
750–1800 cm1) in A, non-osteoarthritis (non-OA) (purple) versus OA
(orange) tibial specimens (difference shown in black), and in B,
non-OA medial (black) versus non-OA lateral (blue) compartments,
and OA medial (green) versus OA lateral (red) compartments.
Figure 3. Results of peripheral quantitative computed tomography
assessing A, the subchondral bone density and B, the subchondral bone
thickness of each tibial compartment, comparing the medial (black
squares) and lateral (blue circles) compartments of non-osteoarthritis
(non-OA) tibial plateaus and the medial (green triangles) and lateral
(red diamonds) compartments of OA tibial plateaus. *  P  0.05.
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10% glycerol, 0.01% bromphenol blue). SDS-PAGE was per-
formed using 7.5% polyacrylamide resolving gel matrix and
4.5% stacking gel in a Mini-Protean II apparatus (Bio-Rad,
UK). After electrophoresis, the gels were stained with Coo-
massie blue (0.005%) to visualize protein, and then destained
with 10% acetic acid and 20% methanol solution. A type I
collagen standard prepared from equine skin and molecular
weight markers were run alongside the samples. Following
staining and destaining, a digital image of the gel was obtained,
and ImageJ software was used to quantify the intensities of the
1- and 2-chain bands (details available from the correspond-
ing author upon request). The 1:2 chain ratio was calculated
using a correction factor (1.16) to account for the smaller 2
polypeptide chain.
Statistical analysis. Spectra were baseline corrected
(750–1800 cm1) using a third-order polynomial (Matlab; The
Mathworks), with values normalized to the phosphate peak
(960 cm1). For multivariate analyses, PCA (unsupervised)
and PCA-linear discriminant analysis (PCA-LDA; supervised)
were performed to facilitate the identification of segregation of
the spectra, based on variance, by forming linear combinations
of the wave numbers and ranking them in order of variance
(Matlab 2012a; The Mathworks) (27,28). The Raman spectra
in each cohort were averaged (Figure 2). Subjectively, there
were few spectral differences between the OA and non-OA
samples; however, subtle differences are difficult to identify by
observing the average spectra. A 3-dimensional scatter plot of
the resulting scores obtained from the multivariate analysis
(PCA) allows for differences to be identified objectively,
because the distance between the scores (expressed as points;
each point represents a spectrum) on the plot is proportional
to the spectral, and therefore the biochemical, similarities.
Univariate analysis was utilized for direct comparison
of the bands of interest, i.e., the ratio of phosphate (960 cm1)
to amide I (1660 cm1), the ratio of phosphate to proline
(920 cm1), the ratio of phosphate to carbonate (1070 cm1),
and the ratio of phosphate to hydroxyproline (885 cm1 
870 cm1), which provides the relative amount of bioapatite to
collagen (29). Peak heights were compared to determine the
ratios. The -chain ratios were analyzed using the Mann-
Whitney U test, as a nonparametric equivalent to the
independent-samples t-test (SPSS; IBM UK). One-way analy-
sis of variance, followed by the Bonferroni post hoc test, was
used to compare the density, thickness, and median spectral
ratios across the multiple groups (Origin 8.6; OriginLab).
Throughout the statistical testing, the number of subjects per
cohort was noted.
RESULTS
Density and thickness of the subchondral bone.
The density of the subchondral bone was significantly
higher across the OA tibial plateaus (mean  SD 950 
100 mg/cm3) compared to the non-OA samples (mean
SD 820  90 mg/cm3; P  0.001) (Figure 3A). In
comparing the tibial compartments, the medial sub-
Figure 4. Principal components analysis (PCA) of the Ramen spectra. A–C, Plot of PCA scores for the non-osteoarthritis (non-OA) tibial
specimens compared to the OA tibial specimens (A), the corresponding PCA loadings plot (B), and the color-coded plot of PCA scores in the
non-OA and OA medial and lateral compartments (color-coded to enable identification of the medial and lateral spectra) (C). D–F, Plot of
PCA–linear discriminant analysis (PCA-LDA) scores for the non-OA and OA medial and lateral compartments (D), the corresponding PCA-LDA
loadings plot (E), and the plot of PCA-LDA scores for the non-OA tibial specimens compared to the OA tibial specimens (F). The data in F are
plotted along the x-axis, and split along the y-axis only for ease of visualization. The loadings plots (B and E) show the axes (linear combination of
the variables) for the PCA-LDA and LDA analyses, respectively. In loadings plots, the larger the peak, the more influence it has on any separation
in the scores plotted along a particular axis.
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chondral bone had a significantly higher structural den-
sity than the lateral subchondral bone (mean  SD
940  94 mg/cm3 versus 884  25 mg/cm3; P  0.005)
in all OA specimens, whereas only 3 of the 10 non-OA
specimens showed a difference in density, albeit not
significant (P 0.2), between compartments. Moreover,
the OA medial compartments were significantly denser
than the non-OA medial compartments (P  0.003)
(Figure 3A).
With regard to subchondral bone thickness, the
medial compartment of the OA specimens was signifi-
cantly thicker than the lateral compartment, and was
significantly thicker in OA specimens compared to
non-OA specimens (Figure 3B). The thickness of the
non-OA medial and lateral compartments was compa-
rable (mean  SD 1.3  0.2 mm).
Raman spectral signatures. Non-OA versus OA.
PCA revealed a large separation of spectra (confidence
interval 0.95) between the non-OA and OA specimens
(Figure 4A). However, there was no difference between
the medial and lateral compartments within each cohort
(Figure 4C).
The spectral differences resolved from PCA can
be identified by interpreting Figure 4B. The first axis
(PC1) shows that the phosphate band (954 cm1 and
966 cm1) was different between the cohorts. The
second axis (PC2) reveals that the second largest differ-
ence was in amide I (1668 cm1 and 1685 cm1) and the
phosphate shoulder (941 cm1). Finally, the third axis
(PC3) shows that the next difference was related to
broad differences across 1597 cm1.
Univariate analysis of the Raman spectral peaks
(Table 1) revealed statistically significant differences
between the cohorts for the phosphate:amide I ratio
(P  0.04) and the bioapatite:collagen ratio (P  0.04),
in the medial and lateral compartments combined.
Medial versus lateral compartments. PCA-LDA
was used to separate the 4 groups, comprising compar-
isons of the non-OA medial versus non-OA lateral
compartments, and OA medial versus OA lateral com-
partments. The findings, shown in Figure 4D, confirm
that there were differences between the non-OA and
OA specimens, and that there were no differences
between compartments within each cohort. The chemi-
cal components that showed the most differences in
intensity between the non-OA and OA specimens, re-
gardless of compartment (Figure 4B), were hydroxypro-
line (858 cm1), C–C collagen backbone (941 cm1),
and phosphate (956 cm1 and 966 cm1).
Medial non-OA versus medial OA, and lateral
non-OA versus lateral OA. Analysis of the non-OA
medial compartment compared to the OA medial com-
partment (Figures 5A and B) revealed a spectral sepa-
ration that could be attributed to differences in the
intensity of phosphate (944 cm1 and 953 cm1), amide
III (1275 cm1), and a broad region across amide I
(1650 cm1). Analysis of the lateral compartment in
non-OA specimens compared to OA specimens (Figures
5C and D) indicated that there was a biochemical
difference, with more intracategory variance, in the
non-OA specimens. The spectral bands contributing
to the differences were the bands at 850 cm1 and
Table 1. Results of Raman spectral and biochemical analyses*
Raman spectral analysis
Biochemical analysis,
1:2 chain ratioPhosphate:amide I Carbonate:phosphate Bioapatite:collagen
Non-OA
Medial compartment 13.12 (4.47) 0.17 (0.02) 8.5 (1.92) 2.0 (1.03–3.15):1.0
Lateral compartment 13.45 (3.36) 0.17 (0.01) 8.99 (2.98) 2.0 (1.44–3.62):1.0
P for comparison 1 1 1 0.5
OA
Medial compartment 13.96 (2.98) 0.18 (0.02) 9.90 (2.11) 3.0 (1.58–8.08):1.0
Lateral compartment 14.70 (3.56) 0.18 (0.01) 10.7 (2.42) 2.3 (1.63–9.90):1.0
P for comparison 1 1 0.3 0.4
Medial  lateral compartments
Non-OA 13.28 (3.86) 0.17 (0.02) 8.75 (2.38) 2.0 (1.03–3.62):1.0
OA 14.33 (3.47) 0.18 (0.02) 10.3 (2.27) 2.6 (1.58–9.90):1.0
P for comparison 0.04† 0.1 0.04† 0.2
Medial compartment
P, non-OA vs. OA 0.4 0.3 0.2 0.03†
* Results of the Raman spectral analysis are the median ratio (interquartile range) determined by univariate analysis for bone mineralization (ratio
of phosphate to amide I), bone turnover (ratio of carbonate to phosphate), and the bioapatite:collagen ratio in osteoarthritis (OA) and non-OA tibial
plateau specimens. Results of the biochemical analysis are the ratio of type I collagen 1 chain, expressed as the median (range), to 2 chain for
each cohort.
† P value is statistically significant at the 95% confidence level.
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910 cm1, and the phosphate bands (963 cm1 and
956 cm1).
Polarization. Analyses of the results from the
polarization/orientation tests showed that the Raman
spectra were sensitive to sample orientation, but the
variations were smaller than the differences between the
samples (details available from the corresponding au-
thor upon request). Therefore, we can conclude that
polarization had no effect on our findings.
Biochemical findings. The OA specimens had a
significantly higher 1:2 chain ratio compared to the
non-OA specimens (P  0.03) (Table 1). The largest
1:2 chain ratio in the non-OA specimens was 3.62:1.0
(lowest ratio 1.03:1.0; mean ratio 2.0:1.0). In the OA
specimens, the largest 1:2 chain ratio was 9.90:1.0
(lowest ratio 1.58:1.0; mean ratio 2.6:1.0).
DISCUSSION
Results from the pQCT, Raman spectral, and
collagen analyses all showed significant cohort-specific
differences between the OA and non-OA samples. The
results support our hypothesis that bone matrix changes
found in OA specimens can be detected with Raman
spectroscopy. An unexpected new finding is that this
spectral difference between OA and non-OA tissue was
discernible in both the lateral and medial compartments.
The OA medial compartment was expected to be differ-
ent, as all OA specimens were confirmed to have grade
IV OA (30) in the medial compartment. The previously
reported enhanced levels of homotrimeric type I colla-
gen in OA bone were confirmed by our findings in the
grossly affected OA medial compartment. However,
elevated levels of homotrimeric collagen and associated
spectral differences were also found in the grossly nor-
mal lateral compartment of the OA specimens, indicat-
ing that the whole joint is affected.
Damage and repair may enhance tissue turnover
in individuals with OA, e.g., during weight-bearing.
Previous studies have suggested that the high tissue
turnover rate and proliferation lead to thickening of
the subchondral bone (31). Differences in the lateral
compartment suggest that underlying biochemical
changes are taking place, leading to dissemination of
gross pathologic alterations across the joint. Although
the lateral compartment is not showing macroscopically
visible/symptomatic changes toward OA, it is exhibiting
small changes, suggestive of early signs of OA, or devel-
oping inherent differences in the bone matrix.
OA of the knee is a painful condition that
changes the loading of the limb, and therefore mechano-
biologic factors may be a part of the changes observed.
Furthermore, the OA cohort could be exhibiting an
inherent difference in bone matrix chemistry, with as-
sociated material properties, which would predispose
individuals to mechanobiologic joint degeneration. This
theory is speculative, but it is known that there can be
different responses of bone to increased and decreased
mechanical loading (32), and that the material proper-
ties of bone across different (nonmutant) strains of a
single species (of mice) can vary by up to 27% (33). The
Figure 5. Principal components analysis (PCA) showing the plot of PCA scores for the non-osteoarthritis (non-OA) and OA medial compartment
(A) and the corresponding loadings plot (B), as well as the plot of PCA scores for the non-OA and OA lateral compartment (C) and the
corresponding loadings plot (D).
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current findings may contribute evidence to suggest that
individual variation is more complex than previously
known, and therefore the findings warrant further inves-
tigation to determine whether they are inherent genetic
differences or preclinical manifestations of disease. Con-
firmation of either finding would be significant, partic-
ularly in providing opportunities for early diagnosis.
Subchondral bone thickness from a healthy joint
is known to be in the average range of 1 mm (SD 0.28)
to 1.2 mm (SD 0.41) for both compartments (34).
Consistent with this, the mean  SD measurement of
subchondral bone thickness in this study, in each of the
non-OA compartments and the OA lateral compart-
ments, was 1.2  0.23 mm. Comparatively, subchondral
bone in the OA medial compartment was significantly
thicker (3.0 0.8 mm), which is consistent with previous
observations in which OA subchondral bone was noted
to be thicker (6). Interestingly, the density of the OA
subchondral bone was increased in the lateral and
medial compartments.
The differences observed between non-OA and
OA specimens could be attributed to the spectral signa-
tures associated with phosphate, amide I, and phenylal-
anine tissue components. This suggests that there are
changes in collagen that may affect mineralization of the
subchondral bone. The spectral, and therefore biochem-
ical, difference between OA and non-OA subchondral
bone should be explored further to identify potential
therapeutic targets for new pharmacologic treatments of
early-stage OA and preclinical OA. Early-stage treat-
ment could result in a delay or reduction in joint
replacements.
The medial compartments in the OA and
non-OA specimens could be distinguished by differences
in the low–wave number shoulder of the phosphate peak
and in the amide I peak. However, differences in the
lateral compartments between OA and non-OA speci-
mens were associated with hydroxyproline/proline,
amide I, and centroid of the phosphate peak, supporting
the theory that there are collagen changes in the bone.
The hydroxylation of proline is an important contributor
to the strength of collagen, as it forms hydrogen bonds
and water bridges, which stabilize the triple helix (35,36).
The distinguishable changes across the 2 compartments
could identify a progression at the late stage of OA
(medial) compared to the early stage of OA (lateral).
The higher mineralization ratio (phosphate:
amide I) in OA compared to non-OA specimens was
consistent with the pQCT density measurements, and
suggests that a change/difference in the bone matrix
composition precedes subchondral bone thickening.
These findings support the theory that a material change
to subchondral bone, rather than just an increase in
volume, occurs. The second band ratio calculation that
supports this finding is the bioapatite:collagen quantifi-
cation, which shows that OA subchondral bone, as
compared to non-OA specimens, has more mineral than
collagen. This demonstrates a definable difference be-
tween the OA and non-OA specimens that can be
resolved by Raman spectroscopy.
Lipid removal was successful, as confirmed by a
lack of lipid-specific peaks at 1300 cm1 and 1750 cm1
(details available from the corresponding author upon
request). This process was important, as lipids are strong
Raman scatterers and their presence could mask the
bone at the small spatial resolutions that were utilized.
The polarization/orientation effects seen were smaller
than the differences due to disease (results available
from the corresponding author upon request). Further-
more, since all of the specimens were measured in the
same orientation (within 10°), any impact from polariza-
tion effects would be minimized. A recent study of
polarization effects on bone confirms the orientation-
induced changes in the peaks. The bioapatite:collagen
peak is the most reliable, as the proline and phosphate
peaks are phase-matched peaks, i.e., they change in
proportion to polarization/orientation (37). In addition,
the validation study revealed that the OA specimens
were more sensitive to polarization/orientation than the
non-OA specimens.
Considering the potential of Raman spectroscopy
as a diagnostic tool, the recently developed technique of
spatially offset Raman spectroscopy (SORS) (38) allows
the acquisition of spectra from up to 4 mm below the
surface, e.g., bone through skin, or through cartilage
arthroscopically (39–43). As these approaches in a clin-
ical setting would be minimally invasive and nondestruc-
tive, and would not involve ionizing radiation, they have
the potential to be a powerful complementary technique
to current technologies. SORS, as a noninvasive, non-
ionizing technique able to probe both the organic and
inorganic phases of bone, has potential to be used as a
diagnostic tool in vivo. The delivery of the laser and
collection of the Raman photons further minimizes the
effects of polarization/orientation associated with the
laser, and the millimeter scale and depth measurement
should reduce the contribution of lipids and probe a
larger area of bone, thus minimizing the effect of hetero-
geneities within the bone structure.
Results of the biochemical analyses showed that
there was less homotrimeric collagen (ratio range 1.6:1
to 9.9:1) than that previously reported (ratio range 4:1 to
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17:1) (8). There may be several reasons for this. First,
this study used bone from tibial plateaus, whereas the
levels previously reported used femoral heads (8). Sec-
ond, the area measured in the femoral heads was a
minimum of 1 cm below the cartilage (mostly epiphyseal
trabecular bone), and therefore unlikely to include
subchondral bone, so there cannot be a direct compar-
ison between our data and those previously reported (8).
Studies have shown that homotrimeric type I
collagen molecules have an increased hydroxyproline
content and increased denaturation temperature com-
pared to heterotrimeric molecules (14). An increased
molecular stability is further supported by the finding
that resistance to cleavage by collagenase is increased
due to less efficient unwinding at the cleavage site (44).
The 1 chain is less hydrophobic than the 2 chain,
which may result in increased water content of the fibril
and, consequently, increased spacing between collagen
molecules (14). The increased distance between collagen
molecules has been implicated in the reduction in im-
mature collagen crosslink levels and decreased mechan-
ical strength observed in type I homotrimer oim mice
(14). Furthermore, because mineralization occurs pref-
erentially in hydrophilic environments, this may explain
the increased mineralization levels of the OA bone.
Molecular simulation studies have suggested that ho-
motrimeric collagen molecules are more flexible and
form kinks more freely than do heterotrimeric mole-
cules, providing an alternative explanation for the in-
creased spacing and decreased intermolecular crosslink-
ing in homotrimeric collagen (45). In previous studies,
the presence of homotrimeric collagen was associated
with a higher rate of collagen turnover (11). However, in
our study, we found no evidence of increased matrix
turnover.
In summary, in the present study, differences
were found between non-OA subchondral bone and the
grossly affected medial compartment of OA subchondral
bone. We were able to detect these changes using a
nondestructive spectroscopic technique. Furthermore,
these differences were comparable to that in the OA
subchondral bone beneath macroscopically intact carti-
lage of the lateral compartment. There was a large
significant difference between the profiles of the
non-OA and OA specimens, which could be due to
predisposition, increased turnover, or change in loading
across the joint. The study results also indicated that the
subchondral bone matrix chemistry across the whole
joint was affected, possibly due to different stages
through the progression of the disease, and thus the
mineralization process was affected. This supports re-
search previously reported in animal models (46,47).
Our findings thus indicate that subchondral bone
changes, or inherent differences, exist in both the medial
and lateral compartments of the OA tibial plateau.
Furthermore, changes can be found beneath visibly
unaffected cartilage of the lateral compartment, indicat-
ing, for the first time, that the joint as a whole is
predisposed to develop OA. Subchondral bone there-
fore represents a key target for therapeutic strategies
(mechanical or pharmaceutical). The detection of bone
matrix chemistry variations, by Raman spectroscopy
coupled with multivariate analysis, in subchondral bone
would facilitate the identification of clinical disease,
including early molecular changes. It is possible that
these changes may be inherent to the individual, and
therefore a better understanding of the changes would
enable identification of those at risk of OA.
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